IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
IMDX
87 hedge funds and large institutions have $282M invested in Insight Molecular Diagnostics Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 33 increasing their positions, 12 reducing their positions, and 5 closing their positions.
Holders
87
Holders Change
+27
Holders Change %
+45%
% of All Funds
1.53%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
34
Increased
33
Reduced
12
Closed
5
Calls
$1.49M
Puts
$783K
Net Calls
+$702K
Net Calls Change
+$398K
Top Buyers
| 1 |
PVI
1
Pura Vida Investments
New York
|
$63.4M |
| 2 |
O
2
OrbiMed
New York
|
$10.9M |
| 3 |
BC
3
Broadwood Capital
New York
|
$87.1M |
| 4 |
SSA
4
Schonfeld Strategic Advisors
New York
|
$8.42M |
| 5 |
5
BlackRock
New York
|
$25.8M |
